These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 30747392
1. Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile. Baños-Hernández CJ, Navarro-Zarza JE, Bucala R, Hernández-Bello J, Parra-Rojas I, Ramírez-Dueñas MG, García-Arellano S, Hernández-Palma LA, Machado-Sulbarán AC, Muñoz-Valle JF. Clin Rheumatol; 2019 Jun; 38(6):1643-1654. PubMed ID: 30747392 [Abstract] [Full Text] [Related]
2. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients. Hernández-Palma LA, García-Arellano S, Bucala R, Llamas-Covarrubias MA, De la Cruz-Mosso U, Oregon-Romero E, Cerpa-Cruz S, Parra-Rojas I, Plascencia-Hernández A, Muñoz-Valle JF. Cytokine; 2019 Mar; 115():89-96. PubMed ID: 30467094 [Abstract] [Full Text] [Related]
3. Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1/Th2/Th17 cytokine profiles and clinical variables. Bautista-Herrera LA, De la Cruz-Mosso U, Morales-Zambrano R, Villanueva-Quintero GD, Hernández-Bello J, Ramírez-Dueñas MG, Martínez-López E, Brennan-Bourdon LM, Baños-Hernández CJ, Muñoz-Valle JF. Clin Exp Med; 2018 May; 18(2):229-235. PubMed ID: 28965181 [Abstract] [Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Llamas-Covarrubias MA, Valle Y, Bucala R, Navarro-Hernández RE, Palafox-Sánchez CA, Padilla-Gutiérrez JR, Parra-Rojas I, Bernard-Medina AG, Reyes-Castillo Z, Muñoz-Valle JF. Cytokine; 2013 Mar; 61(3):759-65. PubMed ID: 23402792 [Abstract] [Full Text] [Related]
6. MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population. Castañeda-Moreno VA, De la Cruz-Mosso U, Torres-Carrillo N, Macías-Islas MA, Padilla-De la Torre O, Mireles-Ramírez MA, González-Pérez O, Ruiz-Sandoval JL, Huerta M, Trujillo X, Ortuño-Sahagún D, Muñoz-Valle JF. J Neuroimmunol; 2018 Jul 15; 320():117-124. PubMed ID: 29661540 [Abstract] [Full Text] [Related]
7. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients. De la Cruz-Mosso U, García-Iglesias T, Bucala R, Estrada-García I, González-López L, Cerpa-Cruz S, Parra-Rojas I, Gámez-Nava JI, Pérez-Guerrero EE, Muñoz-Valle JF. Cell Immunol; 2018 Feb 15; 324():42-49. PubMed ID: 29397904 [Abstract] [Full Text] [Related]
8. Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis. Kuai SG, Ou QF, You DH, Shang ZB, Wang J, Liu J, Zhou XK, Pei H, Huang LH. Infect Dis (Lond); 2016 Feb 15; 48(3):222-8. PubMed ID: 26542751 [Abstract] [Full Text] [Related]
9. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease. Wang FF, Huang XF, Shen N, Leng L, Bucala R, Chen SL, Lu LJ. Arthritis Res Ther; 2013 Feb 15; 15(3):R65. PubMed ID: 23721694 [Abstract] [Full Text] [Related]
10. Macrophage migration inhibitory factor gene polymorphisms (SNP -173 G>C and STR-794 CATT5-8) confer risk of plaque psoriasis: A case-control study. Hernández-Bello J, Rodríguez-Puente M, Gutiérrez-Cuevas J, García-Arellano S, Muñoz-Valle JF, Fafutis-Morris M, Villanueva-Quintero DG, Alvarado-Navarro A. J Clin Lab Anal; 2021 Nov 15; 35(11):e23999. PubMed ID: 34533238 [Abstract] [Full Text] [Related]
11. Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer. Avalos-Navarro G, Del Toro-Arreola A, Daneri-Navarro A, Quintero-Ramos A, Bautista-Herrera LA, Franco Topete RA, Anaya Macias BU, Javalera Castro DI, Morán-Mendoza AJ, Oceguera-Villanueva A, Topete-Camacho A, Muñoz-Valle JF. J Clin Lab Anal; 2020 May 15; 34(5):e23209. PubMed ID: 31978276 [Abstract] [Full Text] [Related]
12. Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus. De la Cruz-Mosso U, Bucala R, Palafox-Sánchez CA, Parra-Rojas I, Padilla-Gutiérrez JR, Pereira-Suárez AL, Rangel-Villalobos H, Vázquez-Villamar M, Angel-Chávez LI, Muñoz-Valle JF. Hum Immunol; 2014 May 15; 75(5):433-9. PubMed ID: 24530749 [Abstract] [Full Text] [Related]
13. Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea. Kim JS, Choi J, Hahn HJ, Lee YB, Yu DS, Kim JW. PLoS One; 2016 May 15; 11(9):e0162477. PubMed ID: 27598332 [Abstract] [Full Text] [Related]
16. Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia. Okazaki S, Hishimoto A, Otsuka I, Watanabe Y, Numata S, Boku S, Shimmyo N, Kinoshita M, Inoue E, Ohmori T, Someya T, Sora I. Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr 20; 83():33-41. PubMed ID: 29305329 [Abstract] [Full Text] [Related]
17. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis. Corallo C, Paulesu L, Cutolo M, Ietta F, Carotenuto C, Mannelli C, Romagnoli R, Nuti R, Giordano N. Clin Exp Rheumatol; 2015 Apr 20; 33(4 Suppl 91):S98-105. PubMed ID: 26005773 [Abstract] [Full Text] [Related]
18. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL. World J Gastroenterol; 2013 Oct 21; 19(39):6656-64. PubMed ID: 24151396 [Abstract] [Full Text] [Related]
19. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Wu SP, Leng L, Feng Z, Liu N, Zhao H, McDonald C, Lee A, Arnett FC, Gregersen PK, Mayes MD, Bucala R. Arthritis Rheum; 2006 Nov 21; 54(11):3661-9. PubMed ID: 17075815 [Abstract] [Full Text] [Related]
20. An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis. Bossini-Castillo L, Campillo-Davó D, López-Isac E, Carmona FD, Simeon CP, Carreira P, Callejas-Rubio JL, Castellví I, Fernández-Nebro A, Rodríguez-Rodríguez L, Rubio-Rivas M, García-Hernández FJ, Madroñero AB, Beretta L, Santaniello A, Lunardi C, Airó P, Hoffmann-Vold AM, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Vonk MC, Voskuyl AE, de Vries-Bouwstra J, Shiels P, Herrick A, Worthington J, Radstake TRDJ, Martin J, Spanish Scleroderma Group. J Rheumatol; 2017 Oct 21; 44(10):1453-1457. PubMed ID: 28668810 [Abstract] [Full Text] [Related] Page: [Next] [New Search]